These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 9072453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impaired heart function and noradrenaline release after ischaemia in stroke-prone spontaneously hypertensive rats.
    Chen H, Azuma M, Maeda K, Kajimoto N, Higashino H.
    Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):664-70. PubMed ID: 10972529
    [Abstract] [Full Text] [Related]

  • 4. Noradrenergic hyperinnervation in the heart of stroke-prone spontaneously hypertensive rats.
    Kondo M, Terada M, Fujiwara T, Arita N, Yano A, Tabei R.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S75-6. PubMed ID: 9072451
    [Abstract] [Full Text] [Related]

  • 5. Noradrenergic hyperinnervation in the heart of stroke-prone spontaneously hypertensive rats (SHRSP).
    Kondo M, Fujiwara T, Tabei R.
    Hypertens Res; 1996 Jun; 19(2):69-73. PubMed ID: 10968198
    [Abstract] [Full Text] [Related]

  • 6. Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension.
    Kim S, Hosoi M, Shimamoto K, Takada T, Yamamoto K.
    Biochem Biophys Res Commun; 1991 Jul 15; 178(1):151-7. PubMed ID: 2069554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat.
    Takeda Y, Miyamori I, Yoneda T, Hurukawa K, Inaba S, Ito Y, Takeda R.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec 15; 22(1):S20-2. PubMed ID: 9072356
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of circadian blood pressure rhythm and target-organ damage in stroke-prone spontaneously hypertensive rats.
    Shimamura T, Nakajima M, Iwasaki T, Hayasaki Y, Yonetani Y, Iwaki K.
    J Hypertens; 1999 Feb 15; 17(2):211-20. PubMed ID: 10067790
    [Abstract] [Full Text] [Related]

  • 16. Role of an endogenous monoamine oxidase inhibitor, isatin, in SHRSP brain.
    Hamaue N, Endo T, Hirafuji M, Yamazaki N, Togashi H, Saito H, Minami M.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec 15; 22(1):S86-7. PubMed ID: 9072455
    [Abstract] [Full Text] [Related]

  • 17. Cardiopulmonary responses of Wistar Kyoto, spontaneously hypertensive, and stroke-prone spontaneously hypertensive rats to particulate matter (PM) exposure.
    Wallenborn JG, Schladweiler MC, Nyska A, Johnson JA, Thomas R, Jaskot RH, Richards JH, Ledbetter AD, Kodavanti UP.
    J Toxicol Environ Health A; 2007 Nov 15; 70(22):1912-22. PubMed ID: 17966062
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats.
    Togashi H, Kimura S, Matsumoto M, Yoshioka M, Minami M, Saito H.
    Stroke; 1996 Mar 15; 27(3):520-5; discussion 525-6. PubMed ID: 8610323
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.